NCT03006445View on ClinicalTrials.gov

Study of FYU-981 in Hyperuricemia With or Without Gout

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

August 23, 2018

Study Completion Date

October 24, 2018

Conditions
Hyperuricemia With or Without Gout
Interventions
DRUG

FYU-981

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
collaborator

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

lead

Fuji Yakuhin Co., Ltd.

INDUSTRY

NCT03006445 - Study of FYU-981 in Hyperuricemia With or Without Gout | Biotech Hunter | Biotech Hunter